[1]
S. Yadav, R. Ganguly, and A. Bhattacharjee, “DISCOVERY OF REPURPOSED FDA APPROVED THERAPEUTIC DRUGS AGAINST SARS COV2 OMICRON VARIANT ”, JASR, vol. 13, no. 08, pp. 20-26, Sep. 2022.